Bonus BioGroup Ltd.

BBIXF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$27,826-$28,529-$38,703-$90,076
Dep. & Amort.$2,793$2,761$2,663$1,476
Deferred Tax$0$0$976$24,757
Stock-Based Comp.$1,628$1,445$7,604$9,851
Change in WC$2,078-$1,329-$1,347-$8,413
Other Non-Cash-$47-$745-$8$22,566
Operating Cash Flow-$21,374-$26,397-$28,815-$39,839
Investing Activities
PP&E Inv.-$342-$824-$6,389-$5,809
Net Acquisitions$0$0$0$0
Inv. Purchases$0-$13,433$0-$367
Inv. Sales/Matur.$12,995$0$0$0
Other Inv. Act.$0$0$96$0
Investing Cash Flow$12,653-$14,257-$6,293-$6,176
Financing Activities
Debt Repay.-$1,298-$1,155-$1,204-$1,650
Stock Issued$3,850$0$3,339$111,353
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$3,715
Financing Cash Flow$2,552-$1,155$2,135$113,418
Forex Effect$91$1,122$7,047-$3,939
Net Chg. in Cash-$6,078-$40,687-$25,926$63,464
Supplemental Information
Beg. Cash$12,937$53,624$79,550$16,086
End Cash$6,859$12,937$53,624$79,550
Free Cash Flow-$21,716-$27,221-$35,204-$45,648
Bonus BioGroup Ltd. (BBIXF) Financial Statements & Key Stats | AlphaPilot